Flex Pharma, Inc. (FLKS) Reaches $4.13 After 9.00% Down Move; Japan Equity Fund Has 0.91 Sentiment

February 22, 2018 - By Vivian Park

The stock of Flex Pharma, Inc. (NASDAQ:FLKS) is a huge mover today! The stock decreased 3.05% or $0.13 during the last trading session, reaching $4.13. About 66,154 shares traded or 31.36% up from the average. Flex Pharma, Inc. (NASDAQ:FLKS) has declined 70.24% since February 22, 2017 and is downtrending. It has underperformed by 86.94% the S&P500.The move comes after 8 months negative chart setup for the $74.22M company. It was reported on Feb, 22 by Barchart.com. We have $3.76 PT which if reached, will make NASDAQ:FLKS worth $6.68 million less.

It closed at $9.13 lastly. It is down 13.94% since February 22, 2017 and is uptrending. It has underperformed by 2.76% the S&P500.

Bulldog Investors Llc holds 1.33% of its portfolio in Aberdeen Japan Equity Fund, Inc. for 528,129 shares. 1607 Capital Partners Llc owns 2.60 million shares or 1.29% of their US portfolio. Moreover, Thomas J. Herzfeld Advisors Inc. has 1.13% invested in the company for 293,968 shares. The New York-based Karpus Management Inc. has invested 0.41% in the stock. City Of London Investment Management Co Ltd, a United Kingdom-based fund reported 377,578 shares.

Among 6 analysts covering Flex Pharma (NASDAQ:FLKS), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Flex Pharma has $4000 highest and $6.0 lowest target. $16.40’s average target is 297.09% above currents $4.13 stock price. Flex Pharma had 8 analyst reports since August 21, 2015 according to SRatingsIntel. H.C. Wainwright maintained the shares of FLKS in report on Thursday, August 3 with “Buy” rating. The stock of Flex Pharma, Inc. (NASDAQ:FLKS) has “Hold” rating given on Tuesday, July 25 by Cantor Fitzgerald. The company was downgraded on Friday, October 14 by Cantor Fitzgerald. On Tuesday, February 13 the stock rating was maintained by Jefferies with “Buy”. The firm earned “Hold” rating on Wednesday, September 2 by Zacks. The company was downgraded on Friday, August 21 by Zacks. The company was initiated on Thursday, September 7 by Roth Capital.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>